Windlas Biotech (NSE:WINDLAS) Tariff Resilience Score: 0/10 (As of Jul. 06, 2026)


NSE:WINDLAS Windlas Biotech Ltd NSE:WINDLAS
91 GF Score
Price ₹871.90
GF Value ₹935.49
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Windlas Biotech Tariff Resilience Score?

Windlas Biotech has the Tariff Resilience Score of 0, which implies that the company might have .

Windlas Biotech has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Windlas Biotech might have .

Windlas Biotech  (NSE:WINDLAS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Windlas Biotech Tariff Resilience Score Related Terms

NSE:WINDLAS
91GF Score
Windlas Biotech Ltd NSE:WINDLAS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Windlas Biotech (NSE:WINDLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Windlas Biotech stock appears to be undervalued. The current stock price of ₹871.90 is trading 6.8% below its estimated GF Value™ of ₹935.49. GuruFocus considers Windlas Biotech to be Fairly Valued.

Key valuation signals for NSE:WINDLAS:

  • Tariff Resilience Score: 0
  • GF Value™: ₹935.49 vs. price of ₹871.90 (6.8% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the NSE:WINDLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Windlas Biotech Business Description

Other Exchanges 543329:India
Address Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
91GF Score

Get the complete analysis for NSE:WINDLAS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹871.90
Price
₹935.49
GF Value